Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014404 · ClinicalTrials.gov registry record · Phase 2
Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00014404: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00014404 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00014404, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of celecoxib may be an effective way to prevent the further development of precancerous lesions in the mouth. PURPOSE: Randomized phase II trial to compare the effectiveness of different regimens of celecoxib in treating patients who have precancerous lesions in the mouth.
Interventions
- DRUG celecoxib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00014404
The ClinicalTrials.gov registry entry for NCT00014404 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which celecoxib is the first listed.
NCT00014404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00014404 about?
NCT00014404 is a clinical study titled "Celecoxib in Treating Patients With Precancerous Lesions of the Mouth". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of celecoxib may be an effective way to prevent the further development of precancerous lesions in the mouth. PURPOSE: Randomized phase II trial to compare the effectiveness of differ...
What is the current status of trial NCT00014404?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-10.
What interventions are being tested in trial NCT00014404?
The interventions under investigation include: celecoxib (DRUG).
Who is sponsoring clinical trial NCT00014404?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.